Viewing Study NCT00746434


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-26 @ 1:06 AM
Study NCT ID: NCT00746434
Status: WITHDRAWN
Last Update Posted: 2016-12-05
First Post: 2008-09-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-11
Start Date Type: None
Primary Completion Date: 2009-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2009-09
Completion Date Type: ESTIMATED
First Submit Date: 2008-09-03
First Submit QC Date: None
Study First Post Date: 2008-09-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-12-02
Last Update Post Date: 2016-12-05
Last Update Post Date Type: ESTIMATED